These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

486 related items for PubMed ID: 10755606

  • 1. The T-type calcium channel blocker mibefradil reduced interstitial and perivascular fibrosis and improved hemodynamic parameters in myocardial infarction-induced cardiac failure in rats.
    Sandmann S, Bohle RM, Dreyer T, Unger T.
    Virchows Arch; 2000 Feb; 436(2):147-57. PubMed ID: 10755606
    [Abstract] [Full Text] [Related]

  • 2. Calcium channel blockade limits cardiac remodeling and improves cardiac function in myocardial infarction-induced heart failure in rats.
    Sandmann S, Claas R, Cleutjens JP, Daemen MJ, Unger T.
    J Cardiovasc Pharmacol; 2001 Jan; 37(1):64-77. PubMed ID: 11152376
    [Abstract] [Full Text] [Related]

  • 3. Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
    Sandmann S, Min JY, Meissner A, Unger T.
    Cardiovasc Res; 1999 Oct; 44(1):67-80. PubMed ID: 10615391
    [Abstract] [Full Text] [Related]

  • 4. Effects of the calcium channel antagonist mibefradil on haemodynamic and morphological parameters in myocardial infarction-induced cardiac failure in rats.
    Sandmann S, Spitznagel H, Chung O, Xia QG, Illner S, Jänichen G, Rossius B, Daemen MJ, Unger T.
    Cardiovasc Res; 1998 Aug; 39(2):339-50. PubMed ID: 9798519
    [Abstract] [Full Text] [Related]

  • 5. Comparison of cardioprotective effects of mibefradil and ramipril in stroke-prone spontaneously hypertensive rats.
    Xia QG, Reinecke A, Dorenkamp M, Storz C, Bitterling H, Penz S, Cleutjens J, Daemen MJ, Simon R, Unger T.
    Acta Pharmacol Sin; 2004 Jun; 25(6):763-8. PubMed ID: 15169629
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
    Min JY, Sandmann S, Meissner A, Unger T, Simon R.
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1038-44. PubMed ID: 10565822
    [Abstract] [Full Text] [Related]

  • 7. Combined effects of ramipril and angiotensin II receptor blocker TCV116 on rat congestive heart failure after myocardial infarction.
    Tao ZW, Huang YW, Xia Q, Xu QW.
    Chin Med J (Engl); 2005 Jan 20; 118(2):146-54. PubMed ID: 15667801
    [Abstract] [Full Text] [Related]

  • 8. Long-acting calcium channel antagonist pranidipine prevents ventricular remodeling after myocardial infarction in rats.
    Takeuchi K, Omura T, Yoshiyama M, Yoshida K, Otsuka R, Shimada Y, Ujino K, Yoshikawa J.
    Heart Vessels; 1999 Jan 20; 14(3):111-9. PubMed ID: 10776803
    [Abstract] [Full Text] [Related]

  • 9. Effects of endothelin ETA receptor blocker LU 135252 on cardiac remodeling and survival in a hypertensive rat model of chronic heart failure.
    Xia QG, Reinecke A, Dorenkamp M, Daemen MJ, Simon R, Unger T.
    Acta Pharmacol Sin; 2006 Nov 20; 27(11):1417-22. PubMed ID: 17049116
    [Abstract] [Full Text] [Related]

  • 10. [Effects of perindopril on left ventricular remodeling and myocardial osteopontin expression in rats with myocardial infarction].
    Zhang YL, Zhou SX, Wang MH, Wang JF.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Nov 20; 26(11):1584-8. PubMed ID: 17121705
    [Abstract] [Full Text] [Related]

  • 11. Calcium channel blockade limits transcriptional, translational and functional up-regulation of the cardiac calpain system after myocardial infarction.
    Sandmann S, Spormann J, Prenzel F, Shaw L, Unger T.
    Eur J Pharmacol; 2002 Oct 18; 453(1):99-109. PubMed ID: 12393065
    [Abstract] [Full Text] [Related]

  • 12. Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11beta-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts.
    Takeda M, Tatsumi T, Matsunaga S, Hayashi H, Kimata M, Honsho S, Nishikawa S, Mano A, Shiraishi J, Yamada H, Takahashi T, Matoba S, Kobara M, Matsubara H.
    Hypertens Res; 2007 May 18; 30(5):427-37. PubMed ID: 17587755
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of beta-adrenergic blocking agent treatment on hemodynamic function and left ventricular remodeling in rats with experimental myocardial infarction: importance of timing of treatment and infarct size.
    Hu K, Gaudron P, Ertl G.
    J Am Coll Cardiol; 1998 Mar 01; 31(3):692-700. PubMed ID: 9502655
    [Abstract] [Full Text] [Related]

  • 14. Effects of a novel angiotensin AT(1) receptor antagonist, HR720, on rats with myocardial infarction.
    Xia QG, Chung O, Spitznagel H, Sandmann S, Illner S, Rossius B, Jähnichen G, Reinecke A, Gohlke P, Unger T.
    Eur J Pharmacol; 1999 Dec 03; 385(2-3):171-9. PubMed ID: 10607873
    [Abstract] [Full Text] [Related]

  • 15. Central infusion of aldosterone synthase inhibitor attenuates left ventricular dysfunction and remodelling in rats after myocardial infarction.
    Huang BS, White RA, Ahmad M, Tan J, Jeng AY, Leenen FH.
    Cardiovasc Res; 2009 Feb 15; 81(3):574-81. PubMed ID: 18689429
    [Abstract] [Full Text] [Related]

  • 16. Differential effects of olmesartan and ramipril on inflammatory response after myocardial infarction in rats.
    Sandmann S, Li J, Fritzenkötter C, Spormann J, Tiede K, Fischer JW, Unger T.
    Blood Press; 2006 Feb 15; 15(2):116-28. PubMed ID: 16754275
    [Abstract] [Full Text] [Related]

  • 17. Significance of timing of angiotensin AT1 receptor blockade in rats with myocardial infarction-induced heart failure.
    Xia QG, Chung O, Spitznagel H, Illner S, Jänichen G, Rossius B, Gohlke P, Unger T.
    Cardiovasc Res; 2001 Jan 15; 49(1):110-7. PubMed ID: 11121802
    [Abstract] [Full Text] [Related]

  • 18. Effects of mibefradil, a T- and L-type calcium channel blocker, on cardiac remodeling in the UM-X7.1 cardiomyopathic hamster.
    Villame J, Massicotte J, Jasmin G, Dumont L.
    Cardiovasc Drugs Ther; 2001 Jan 15; 15(1):41-8. PubMed ID: 11504162
    [Abstract] [Full Text] [Related]

  • 19. Long-term but not short-term p38 mitogen-activated protein kinase inhibition improves cardiac function and reduces cardiac remodeling post-myocardial infarction.
    Kompa AR, See F, Lewis DA, Adrahtas A, Cantwell DM, Wang BH, Krum H.
    J Pharmacol Exp Ther; 2008 Jun 15; 325(3):741-50. PubMed ID: 18334667
    [Abstract] [Full Text] [Related]

  • 20. The ACE 2 activator diminazene aceturate (DIZE) improves left ventricular diastolic dysfunction following myocardial infarction in rats.
    Castardeli C, Sartório CL, Pimentel EB, Forechi L, Mill JG.
    Biomed Pharmacother; 2018 Nov 15; 107():212-218. PubMed ID: 30092400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.